David Kabakoff

David Kabakoff

Chairman presso NEXTCURE, INC.

Patrimonio netto: 138 789 $ in data 31/03/2024

76 anni
Health Technology
Commercial Services
Health Services

Profilo

David joined the HealthQuest team in 2012 to leverage decades of experience as an entrepreneur in the diagnostics and biotech fields.
While a chemist by training, the companies that David has led as President, CEO or Chairman have produced billions of dollars in returns for investors and employees.
David brings over 44 years of industry experience to HealthQuest (14 of which have been in healthcare investing), and currently serves on the Board of portfolio company RareCyte, and previously served on the Boards of Lineagen (sold to Bionanogenomics), Biotheranostics (sold to Hologic) and Castle Biosciences (CSTL).
As an operator David’s successes include leading the development of some of the diagnostic industry’s most iconic products like the first yes/no color changing pregnancy test, the PSA test for prostate cancer and the rapid strep throat test, plus numerous cancer diagnostics.
He served in senior executive positions at Hybritech, was President of Dura Pharmaceuticals, CEO of Spiros Development Corp., Corvas International and co-founder/CEO of Salmedix.
Each of the products he developed succeeded because it made a large impact on the medical management of patients and David keeps a keen eye out for innovative products when he considers investments for HealthQuest.
He has served as Chairman of Trius Therapeutics (acquired by Cubist), Chairman of Cebix Inc., Chairman of Amplimmune, Inc. (acquired by AstraZeneca), and as a Director of InterMune, Inc. (acquired by Roche), Principia Biopharma (acquired by Sanofi), and Allylix, Inc. (acquired by Evolva).
David earned his BA in chemistry from Case Western Reserve University and then his PhD from Yale University.
He lives with his wife and enjoys fine wine, print collecting, skiing and golf.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
22/06/2023 62 237 ( 0.22% ) 138 789 $ 31/03/2024

Posizioni attive di David Kabakoff

SocietàPosizioneInizio
NEXTCURE, INC. Chairman 01/12/2015
Private Equity Investor 01/01/2009
Director/Board Member -
Director/Board Member -
Director/Board Member 18/09/2018
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tutte le posizioni attive di David Kabakoff

Precedenti posizioni note di David Kabakoff

SocietàPosizioneFine
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di David Kabakoff

Formazione di David Kabakoff

Case Western Reserve University Undergraduate Degree
Yale University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di David Kabakoff

Relazioni

100 +

Relazioni di 1° grado

30

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
CASTLE BIOSCIENCES, INC.

Health Technology

NEXTCURE, INC.

Health Technology

Aziende private26

Health Technology

Corvas International, Inc.

Health Technology

Spiros Development Corp II, Inc.

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Miscellaneous

Health Technology

Health Technology

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. David Kabakoff